Unlocking a Combination Therapy for New Onset T1D

A new study is further assessing if a novel combination of drugs could help treat new onset type 1 diabetes University of Florida researchers are ready to launch a new clinical study to examine if a combination of two U.S Food and Drug Administration (FDA) approved drugs, antithymocyte globulin (ATG) and granulocyte colony stimulating factor […]

Ride Registration to Open January 21

The JDRF Ride to Cure Diabetes is a destination cycling event that takes place in several stunning locations across the United States.  Participants can bike for their choice of distance, usually between 30 and 100 miles. Cyclists of all skill levels come together to raise funds for JDRF and to take part in a weekend-long […]

January 2015 Cure Champion

On October 27, 2009 my 9-year-old son Joseph, was diagnosed with type 1 diabetes (T1D).  It was overwhelming coming home from the hospital. My husband and I just looked at each other, in shock that our child’s health, and very life, was in our inexperienced hands. We were lucky to have a small group of […]

December Cure Champion

My family and I have been active supporters since my son, Tommy, was diagnosed in 2009, five years ago this month. Tommy was diagnosed just before Christmas 2009, when he was 14. We went directly from our pediatrician’s office to Children’s Hospital in Boston, and spent the next 3 snowy days and nights going through […]

Consider JDRF at Year End

JDRF is the only organization with a strategic research plan to end type 1 diabetes (T1D).  For more than four decades, we have been renowned as a highly effective research organization with remarkable efficiency in directing donor dollars toward achieving our goal of a world without T1D. JDRF has always been dedicated to maintaining the […]

A song worth more than a listen

Korn releases exclusive download to benefit T1D research What can one voice raised against type 1 diabetes (T1D) do? If you’re Jonathan Davis, lead singer of acclaimed rock band Korn, one voice can reach millions to help people living with T1D. Jonathan’s young son, Zeppelin, was diagnosed with T1D just over a year ago, and […]

Advancing a Key Artificial Pancreas Technology

Stable liquid glucagon developed by JDRF partner Xeris evaluated in first clinical study The JDRF Artificial Pancreas (AP) project is focused on accelerating the development of commercially-viable AP systems that better mimic the biological function of the pancreas and reduce the daily burden of managing type 1 diabetes (T1D). To achieve this goal, JDRF funds […]

Improving Beta Cell Health and Survival

JDRF-funded clinical study to test marketed drug to improve beta cell health and survival in T1D JDRF recently awarded a $2.1 million grant to Anath Shalev, M.D., director of the University of Alabama’s (UAB) Comprehensive Diabetes Center, to test the impact of a common blood pressure drug called verapamil on the health and survival of […]

Need a New Athletic Goal? Give this a Tri!

Since 2007 the JDRF New England Chapter has been fortunate to be the charity partner of the Cohasset Triathlon raising more than $1 million for type 1 diabetes research. Created and organized by Streamline Events, the Cohasset Tri has become a leader in the endurance event market— consistently selling out within the first hour of […]